The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Molecular Targets in Pulmonary Fibrosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis
Demedts, M., Behr, J., Buhl, R., Costabel, U., Dekhuijzen, R., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., Laurent, F., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042976 · Cited by 964
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-571oc · Cited by 954
Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., & Borok, Z. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62351-6 · Cited by 951
Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., & Kitani, A. (2006) · Nature Medicine · doi:10.1038/nm1332 · Cited by 889
Regulation of PDGF and its receptors in fibrotic diseases
Bonner, J. C. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.006 · Cited by 768
Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis
Grünert, S., Jechlinger, M., & Beug, H. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1175 · Cited by 678
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Idiopathic Pulmonary Fibrosis: Relationship between Histopathologic Features and Mortality
KING, T. E., SCHWARZ, M. I., BROWN, K., TOOZE, J. A., COLBY, T. V., WALDRON, J. A., FLINT, A., THURLBECK, W., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2001056 · Cited by 628
Zuo, F., Kaminski, N., Eugui, E., Allard, J., Yakhini, Z., Ben-Dor, A., Lollini, L., Morris, D., Kim, Y., DeLustro, B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092134099 · Cited by 620
Ziesche, R., Hofbauer, E., Wittmann, K., Petkov, V., & Block, L.-H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411703 · Cited by 586
Daniels, C. E., Wilkes, M. C., Edens, M., Kottom, T. J., Murphy, S. J., LIMPER, A. H., & Leof, E. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19603 · Cited by 574
The Myofibroblast in Pulmonary Fibrosis*
Phan, S. H. (2002) · Chest · doi:10.1378/chest.122.6_suppl.286s · Cited by 521
Zhang, K., Rekhter, M. D., Gordon, D., & Phan, S. H. (1994) · PubMed · Cited by 480
CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., & Toews, G. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62289-4 · Cited by 441
Anticoagulant Therapy for Idiopathic Pulmonary Fibrosis
Kubo, H., Nakayama, K., Yanai, M., Suzuki, T., Yamaya, M., Watanabe, M., & Sasaki, H. (2005) · Chest · doi:10.1378/chest.128.3.1475 · Cited by 440
Gharaee-Kermani, M., Denholm, E. M., & Phan, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17779 · Cited by 435
Raghu, G., Depaso, W. J., Cain, K., Hammar, S. P., Wetzel, C. E., Dreis, D. F., Hutchinson, J., Pardee, N. E., & Winterbauer, R. H. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.2.291 · Cited by 414
Jenkins, R. G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27183 · Cited by 314
The Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis
Moore, B. B., Murray, L., Das, A., Wilke, C. A., Herrygers, A. B., & Toews, G. B. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0239oc · Cited by 309
Gurujeyalakshmi, G., & Giri, S. N. (1995) · Experimental Lung Research · doi:10.3109/01902149509050842 · Cited by 303
Multiplicity of the interactions of Wnt proteins and their receptors
Kikuchi, A., Yamamoto, H., & Kishida, S. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.11.001 · Cited by 283
Kolb, M., Margetts, P. J., Sime, P. J., & Gauldie, J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.6.l1327 · Cited by 270
Leask, A., & Abraham, D. J. (2003) · Biochemistry and Cell Biology · doi:10.1139/o03-069 · Cited by 261
Bonniaud, P., Margetts, P. J., Kolb, M., Schroeder, J. A., Kapoun, A. M., Damm, D., Murphy, A., Chakravarty, S., Dugar, S., Higgins, L., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-612oc · Cited by 256
Chambers, R. C., Leoni, P., Blanc-Brude, O. P., Wembridge, D. E., & Laurent, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003188200 · Cited by 233
Self-citationStratton, R., Shiwen, X., Martini, G., Holmes, A., Leask, A., Haberberger, T., Martin, G. R., Black, C. M., & Abraham, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12020 · Cited by 232
Imatinib as a Novel Antifibrotic Agent in Bleomycin-induced Pulmonary Fibrosis in Mice
Aono, Y., Nishioka, Y., Inayama, M., Ugai, M., Kishi, J., Uehara, H., Izumi, K., & Sone, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-531oc · Cited by 231
Corticosteroids for idiopathic pulmonary fibrosis
Richeldi, L., Davies, H. R. H. R., Spagnolo, P., & Luppi, F. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002880 · Cited by 219
Howell, D. C. J., Johns, R. H., Lasky, J. A., Shan, B., Scotton, C. J., Laurent, G. J., & Chambers, R. C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62354-1 · Cited by 218
Self-citationChemokine/Cytokine Cocktail in Idiopathic Pulmonary Fibrosis
Agostini, C., & Gurrieri, C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-010tk · Cited by 197
Fibroblast Foci Are Not Discrete Sites of Lung Injury or Repair: The Fibroblast Reticulum
Cool, C. D., Groshong, S. D., Rai, P. R., Henson, P. M., Stewart, J. S., & Brown, K. K. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-205oc · Cited by 196
Howell, D. C. J., Goldsack, N. R., Marshall, R. P., McAnulty, R. J., Starke, R., Purdy, G., Laurent, G. J., & Chambers, R. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62525-4 · Cited by 186
Self-citationKolodsick, J. E., Toews, G. B., Jakubzick, C., Hogaboam, C., Moore, T. A., McKenzie, A., Wilke, C. A., Chrisman, C. J., & Moore, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4068 · Cited by 185
Clinical significance of MCP‐1 levels in BALF and serum in patients with interstitial lung diseases
Suga, M., Iyonaga, K., Ichiyasu, H., Saita, N., Yamasaki, H., & Ando, M. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14b23.x · Cited by 182
Nagaoka, I., Trapnell, B. C., & Crystal, R. G. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114669 · Cited by 181
Allen, J. T., Knight, R. A., Bloor, C. A., & Spiteri, M. A. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.21.6.3719 · Cited by 180
FIZZ1 Stimulation of Myofibroblast Differentiation
Liu, T., Dhanasekaran, S. M., Jin, H., Hu, B., Tomlins, S. A., Chinnaiyan, A. M., & Phan, S. H. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63218-x · Cited by 179
Current Perspectives on the Treatment of Idiopathic Pulmonary Fibrosis
Walter, N., Collard, H. R., & King, T. E. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200602-016tk · Cited by 174
Liu, T., Jin, H., Ullenbruch, M., Hu, B., Hashimoto, N., Moore, B., McKenzie, A., Lukacs, N. W., & Phan, S. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3425 · Cited by 167
Therapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells
Jakubzick, C., Choi, E. S., Joshi, B. H., Keane, M. P., Kunkel, S. L., Puri, R. K., & Hogaboam, C. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2684 · Cited by 167
CXCL11 Attenuates Bleomycin-induced Pulmonary Fibrosis via Inhibition of Vascular Remodeling
Burdick, M. D., Murray, L. A., Keane, M. P., Xue, Y. Y., Zisman, D. A., Belperio, J. A., & Strieter, R. M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1164oc · Cited by 164
Prevention of Bleomycin-induced Lung Fibrosis by Aerosolization of Heparin or Urokinase in Rabbits
Günther, A., Lübke, N., Ermert, M., Schermuly, R. T., Weissmann, N., Breithecker, A., Markart, P., Ruppert, C., Quanz, K., Ermert, L., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201082 · Cited by 164
Collard, H. R., Ryu, J. H., Douglas, W. W., Schwarz, M. I., Curran‐Everett, D., King, T. E., & Brown, K. K. (2004) · CHEST Journal · doi:10.1378/chest.125.6.2169 · Cited by 159
The Extrapulmonary Origin of Fibroblasts: Stem/Progenitor Cells and Beyond
Lama, V. N., & Phan, S. H. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200512-133tk · Cited by 156
Bonniaud, P., Martin, G. E. M., Margetts, P. J., Ask, K., Robertson, J. V., Gauldie, J., & Kolb, M. R. J. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0158oc · Cited by 154
CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis
Gharaee‐Kermani, M., McCullumsmith, R. E., Charo, I. F., Kunkel, S. L., & Phan, S. H. (2003) · Cytokine · doi:10.1016/j.cyto.2003.08.003 · Cited by 148
Ziegenhagen, M. W., Zabel, P., Zissel, G., Schlaak, M. S., & Müller–Quernheim, J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9705014 · Cited by 139
Adenoviral Gene Transfer of Connective Tissue Growth Factor in the Lung Induces Transient Fibrosis
Bonniaud, P., Margetts, P. J., Kolb, M., Haberberger, T., Kelly, M. M., Robertson, J. V., & Gauldie, J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1254oc · Cited by 134
Pathogenesis and Natural History of Usual Interstitial Pneumonia
Strieter, R. M. (2005) · CHEST Journal · doi:10.1378/chest.128.5_suppl_1.526s · Cited by 129
Hodges, R. J., Jenkins, G. R., Wheeler-Jones, C. P. D., Copeman, D. M., Bottoms, S. E., Bellingan, G. J., Nanthakumar, C. B., Laurent, G. J., Hart, S. L., Foster, M. L., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63423-2 · Cited by 124
Wnt Signaling and Pulmonary Fibrosis
Morrisey, E. E. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64271-x · Cited by 123
Immunomodulatory agents for idiopathic pulmonary fibrosis
Davies, H. R. H. R., Richeldi, L., & Walters, E. H. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003134 · Cited by 116
Blanc‐Brude, O., Archer, F., Leoni, P., et al. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.021 · Cited by 113
Coagulation cascade proteases and tissue fibrosis
Chambers, R. C., & Laurent, G. J. (2001) · Biochemical Society Transactions · doi:10.1042/bst0300194 · Cited by 108
Self-citationPulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
Nadrous, H. F., Pellikka, P. A., Krowka, M. J., Swanson, K. L., Chaowalit, N., Decker, P. A., & Ryu, J. H. (2004) · CHEST Journal · doi:10.1378/chest.126.2.438 · Cited by 105
Ask, K., Martin, G. E. M., Kolb, M., & Gauldie, J. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200602-021tk · Cited by 93
The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats: Fig. 1.—
Simler, N., Howell, D. C. J., Marshall, R. P., Goldsack, N., Hasleton, P. S., Laurent, G. J., Chambers, R. C., & Egan, J. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00281602 · Cited by 90
Self-citationEffects of Interferon-γ 1b on Biomarker Expression in Patients with Idiopathic Pulmonary Fibrosis
Strieter, R. M., Starko, K. M., Enelow, R. I., Noth, I., & Valentine, V. G. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200312-1670oc · Cited by 87
Riha, R. L., Duhig, E., Clarke, B. E., Steele, R. H., Slaughter, R., & Zimmerman, P. V. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00244002 · Cited by 85
CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis
Inoue, T., Fujishima, S., Ikeda, E., Yoshie, O., Tsukamoto, N., Aiso, S., Aikawa, N., Kubo, A., Matsushima, K., & Yamaguchi, K. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00110203 · Cited by 81
Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice
Brewer, G. J., Ullenbruch, M. R., Dick, R., Olivarez, L., & Phan, S. H. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2003.20 · Cited by 80
Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis
Antoniou, K. M., Nicholson, A. G., Dimadi, M., Malagari, K. S., Latsi, P. I., Rapti, A., Tzanakis, Ν., Trigidou, R., Polychronopoulos, V., & Bouros, D. E. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00032605 · Cited by 80
Kaminski, N., & Rosas, I. O. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-011tk · Cited by 78
Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts
Bogatkevich, G. S., Gustilo, E. M., Oates, J. C., et al. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00448.2003 · Cited by 65
Nadrous, H. F., Ryu, J. H., Douglas, W. W., Decker, P. A., & Olson, E. J. (2004) · CHEST Journal · doi:10.1016/s0012-3692(15)31155-7 · Cited by 61
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury
Failla, M., Genovese, T., Mazzon, E., Gili, E., Muià, C., Sortino, M. A., Crimi, N., Caputi, A. P., Cuzzocrea, S., & Vancheri, C. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-137 · Cited by 48
Mageto, Y. N., Flaherty, K., Brown, K., Fong, A., & Raghu, G. (2004) · CHEST Journal · doi:10.1378/chest.126.4_meetingabstracts.773s-a · Cited by 31
Promising pharmacologic innovations in treating pulmonary fibrosis
Bhatt, N., Baran, C., ALLEN, J., MAGRO, C. M. J., & Marsh, C. B. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.003 · Cited by 28
Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches
Raghu, G. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00086606 · Cited by 24
Raghu, G., Lasky, J. A., Costabel, U., Brown, K., Cottin, V., Thomeer, M., Utz, J. P., & McDermott, L. M. (2005) · CHEST Journal · doi:10.1378/chest.128.4_meetingabstracts.496s-a · Cited by 20
Chen, J., Ziboh, V. A., & Giri, S. N. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36516-4 · Cited by 16
Cited by
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94753 · Cited by 905
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
The myofibroblast matrix: implications for tissue repair and fibrosis
Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776
The Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers
Fernandez, I. E., & Eickelberg, O. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201203-023aw · Cited by 679
Metadata
- Authors
- Scotton, C. J., & Chambers, R. C.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 132
- Issue
- 4
- Pages
- 1311-1321
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2019431738
- Cited by
- 538
- References
- 79
- FWCI
- 21.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.